ALLISON RAMEY: Open Payments
NPI 1306430681 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$834 in 42 payments from 12 companies in 2025. Trend: 2023 $241 · 2024 $486 · 2025 $834
Food & beverage: $834
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 13 | $268 |
| Sumitomo Pharma America, Inc. | 7 | $150 |
| Biogen, Inc. | 5 | $135 |
| MILLICENT US INC | 4 | $79 |
| Exeltis, USA Inc. | 2 | $42 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $41 |
| Organon LLC | 2 | $31 |
| Novo Nordisk Inc | 1 | $21 |
| PFIZER INC. | 1 | $20 |
| CHANNEL MEDSYSTEMS, INC. | 1 | $16 |
Products named: Veozah, MYFEMBREE, ZURZUVAE, INTRAROSA, SLYND, NEXPLANON, Wegovy, FEMRING.
Industry payments across SC — which companies pay providers there.
